The global Neuroblastoma Drugs market size was valued at US$ 1.28 billion in 2024 and is projected to reach US$ 1.89 billion by 2030, at a CAGR of 6.7% during the forecast period 2024-2030. United States Neuroblastoma Drugs market size was valued at US$ 418.6 million in 2024 and is projected to US$ 598.4 million by 2030, at a CAGR of 6.1% during the forecast period 2024-2030.Download FREE Sample..
